Sabra Healthcare REIT Redeems Senior Notes and Optimizes Capital

Sabra Healthcare REIT ( (SBRA) ) has shared an update.

On July 30, 2025, Sabra Health Care REIT, Inc. and its subsidiaries entered into a $500 million unsecured credit agreement with several financial institutions, with the potential to increase borrowings to $1 billion. The agreement includes interest rate swaps that fix the SOFR portion of the interest rate, resulting in an effective rate of 4.64% through 2030. Additionally, Sabra redeemed its 5.125% Senior Notes due 2026 on July 31, 2025, at a cash redemption price of 100.575% of the principal, plus accrued interest. These financial maneuvers are expected to optimize Sabra’s capital structure and potentially enhance its financial flexibility.

The most recent analyst rating on (SBRA) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on Sabra Healthcare REIT stock, see the SBRA Stock Forecast page.

Spark’s Take on SBRA Stock

According to Spark, TipRanks’ AI Analyst, SBRA is a Outperform.

Sabra Healthcare REIT shows strong financial performance with improving profitability and robust cash flow. Technical indicators suggest bullish momentum, although the stock’s high P/E ratio indicates it may be overvalued. Positive earnings call highlights and strategic corporate events contribute to a favorable outlook, despite some external challenges.

To see Spark’s full report on SBRA stock, click here.

More about Sabra Healthcare REIT

Sabra Health Care REIT, Inc. operates in the healthcare real estate investment trust (REIT) industry, focusing on owning and investing in healthcare-related properties. Its primary services include managing a portfolio of skilled nursing facilities, senior housing, and other healthcare properties, primarily in the United States and Canada.

Average Trading Volume: 2,561,392

Technical Sentiment Signal: Strong Buy

Current Market Cap: $4.32B

See more data about SBRA stock on TipRanks’ Stock Analysis page.